The epidemiological and clinical characteristics study on epilepsy in 8 ethnic groups of China

Yu, Zhipeng; Dong, Kai; Chang, Hong; Huang, Xiaoqin; Ren, Yanping; Fan, Chunqiu; Ma, Qingfeng; Song, Haiqing; Zhang, Qian; Zhang, Jing; Huang, LiYuan

doi:10.1016/j.eplepsyres.2017.10.020

Cited by 5 publications

(2 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies from eastern and northeastern China, mostly on ethnic Han groups, found modest variations in the epilepsy treatment gap estimates. In contrast, those from other ethnic groups reported higher estimates with wide variations (44% to 100%) between groups 17,[41][42][43] . These variations were noted despite similar methodologies used in the studies.…”

Section: Within-country Time Trends and Variationsmentioning

confidence: 99%

Temporal trends in the epilepsy treatment gap in low- and low-middle-income countries: A meta-analysis

Singh

Mahajan

Singh

et al. 2022

Journal of the Neurological Sciences

View full text Add to dashboard Cite

Section: Within-country Time Trends and Variationsmentioning

confidence: 99%

Temporal trends in the epilepsy treatment gap in low- and low-middle-income countries: A meta-analysis

Singh

Mahajan

Singh

et al. 2022

Journal of the Neurological Sciences

View full text Add to dashboard Cite

“…In China, it has been reported that only 67.8% of patients with newly diagnosed epilepsy receive rational antiepileptic initial treatment, 77.5% of which were monotherapies [ 11 ]. According to recent investigations, the epilepsy treatment gap varies significantly between different areas and ethnicities and is especially high in western China [ 12 , 13 ]; this may due to the sociodemographic factors. The population of western China accounts for nearly one-third of China’s total population, and the population in western China is less educated than populations in other regions.…”

Section: Introductionmentioning

confidence: 99%

Sociodemographic factors associated with the first administration of anti-seizure medication in patients with focal epilepsy in Western China

Guo

Yang

et al. 2021

BMC Neurol

View full text Add to dashboard Cite

Background Epilepsy is a severe chronic neurologic disease with a prevalence of 0.7% worldwide; anti-seizure medications (ASMs) are the mainstay of epilepsy treatment. The effects of sociodemographic factors on the characteristics of initial treatment in patients with newly diagnosed focal epilepsy in Western China are unknown. This study was conducted to explore sociodemographic factors associated with initial treatment characteristics. Methods Patients with focal epilepsy on continuous ASM treatment who visited to our epilepsy center at Sichuan Provincial People’s Hospital between January 2018 and December 2019 were recruited. Data on initial treatment status and sociodemographic variables were obtained from the patients with a questionnaire designed by our researchers. We examined whether sociodemographic factors were associated with epileptic patients’ access to neurologists and prescriptions of individual ASMs. Results A total of 569 patients completed this study. We found that patients with a higher education level, aged < 16 years, and with a higher household disposable income were more likely to receive treatment from a neurologist than their counterparts. Patients with a lower personal income level and who were treated at a junior hospital were more likely to receive prescriptions for carbamazepine, and those who were younger than 16 years were less likely to receive prescriptions for carbamazepine and oxcarbazepine. Patients with a higher education level, with a higher household disposable income level, who were younger than 16 years, and who were treated at a senior hospital were more likely to receive prescriptions for levetiracetam than their counterparts. Adult, female patients with focal epilepsy treated at a senior hospital were more likely to receive prescriptions for lamotrigine. Conclusions This observation suggests that sociodemographic characteristics are associated with access to neurologists and prescriptions of individual antiepileptic drugs. These data may help public health officials establish guidelines for doctors and distribute resources according to the needs of different patient groups.

show abstract

Status of epilepsy in the tropics: An overlooked perspective

et al. 2023

View full text Add to dashboard Cite

Epilepsy is one of the most common serious chronic neurological diseases affecting people of all ages globally. It is characterized by recurrent seizures. About 50 million people worldwide have epilepsy. Indubitably, people with epilepsy (PWE) may be without access to appropriate treatment. Many studies have examined the molecular mechanisms and clinical aspects of epilepsy; nonetheless, the treatment gap exists in some special areas. In the tropics, the specific geographical and ecological conditions and a lack of medical resources result in neglect or delay of diagnosis for PWE. Herein, we summarized the epidemiology of epilepsy in the tropics and discussed the disease burden and existing problems, aiming to offer a medical environment for patients in need and highlight the importance of reducing the epileptic disease burden in tropical countries.

show abstract

The epidemiological and clinical characteristics study on epilepsy in 8 ethnic groups of China

Cited by 5 publications

References 25 publications

Temporal trends in the epilepsy treatment gap in low- and low-middle-income countries: A meta-analysis

Temporal trends in the epilepsy treatment gap in low- and low-middle-income countries: A meta-analysis

Sociodemographic factors associated with the first administration of anti-seizure medication in patients with focal epilepsy in Western China

Status of epilepsy in the tropics: An overlooked perspective

Contact Info

Product

Resources

About